
Contract Research
Fusion of Technologies Instead of developing commodity products, CCSB focuses on specialty APIs manufactured by a sophisticated fusion of fermentation / synthesis technologies in Taiwan.
The products include:
Immunosuppressants: Mycophenolate mofetil, Rapamycin (Sirolimus) and Tacrolimus Derivative of Rapamycin: Everolimus, Temsirolimus, Zotarolimus and Biolimus Echinocandin: Caspofungin, Micafungin and AnidulafunginFusion of Technologies
Products with Status Development
Product | CAS | Specification | Status |
---|---|---|---|
Everolimus | 9003-97-8 | In-house | Development |
Caspofungin Acetate | 179463-17-3 | In-house | Development |
Eletriptan HBr | 177834-92-3 | In-house | Development |
Temsirolimus | 162635-04-3 | In-house | Development |
Products with Status Investigation
Product | CAS | Specification | Status |
---|---|---|---|
Micafungin Sodium | 208538-73-2 | In-house | Investigation |
Anidulafungin | 166663-25-8 | In-house | Investigation |
Zotarolimus | 221877-54-9 | In-house | Investigation |
Biolimus | 851536-75-9 | In-house | Investigation |